These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26839353)

  • 1. Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice.
    Strecker JK; Olk J; Hoppen M; Gess B; Diederich K; Schmidt A; Schäbitz WR; Schilling M; Minnerup J
    Stroke; 2016 Mar; 47(3):852-62. PubMed ID: 26839353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.
    Pösel C; Scheibe J; Kranz A; Bothe V; Quente E; Fröhlich W; Lange F; Schäbitz WR; Minnerup J; Boltze J; Wagner DC
    Stroke; 2014 Aug; 45(8):2431-7. PubMed ID: 24984745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands.
    Lombaert IM; Wierenga PK; Kok T; Kampinga HH; deHaan G; Coppes RP
    Clin Cancer Res; 2006 Mar; 12(6):1804-12. PubMed ID: 16551865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct.
    Hokari M; Kuroda S; Chiba Y; Maruichi K; Iwasaki Y
    Cytokine; 2009 May; 46(2):260-6. PubMed ID: 19286390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization.
    Minamino K; Adachi Y; Okigaki M; Ito H; Togawa Y; Fujita K; Tomita M; Suzuki Y; Zhang Y; Iwasaki M; Nakano K; Koike Y; Matsubara H; Iwasaka T; Matsumura M; Ikehara S
    Stem Cells; 2005 Mar; 23(3):347-54. PubMed ID: 15749929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells.
    Kawada H; Takizawa S; Takanashi T; Morita Y; Fujita J; Fukuda K; Takagi S; Okano H; Ando K; Hotta T
    Circulation; 2006 Feb; 113(5):701-10. PubMed ID: 16461843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.
    England TJ; Abaei M; Auer DP; Lowe J; Jones DR; Sare G; Walker M; Bath PM
    Stroke; 2012 Feb; 43(2):405-11. PubMed ID: 22198983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain.
    Buga AM; Scheibe J; Moller K; Ciobanu O; Posel C; Boltze J; Popa-Wagner A
    Curr Neurovasc Res; 2015; 12(2):155-62. PubMed ID: 25760217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice.
    Osada T; Watanabe M; Hasuo A; Imai M; Suyama K; Sakai D; Kawada H; Matsumae M; Mochida J
    J Neurosurg Spine; 2010 Oct; 13(4):516-23. PubMed ID: 20887150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF and/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro.
    Zhang Y; Adachi Y; Iwasaki M; Minamino K; Suzuki Y; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S
    Oncol Rep; 2006 Jun; 15(6):1523-7. PubMed ID: 16685390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke.
    Gautier S; Ouk T; Tagzirt M; Lefebvre C; Laprais M; Pétrault O; Dupont A; Leys D; Bordet R
    J Neuroinflammation; 2014 May; 11():96. PubMed ID: 24885160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke.
    Sugiyama Y; Yagita Y; Oyama N; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
    Stroke; 2011 Mar; 42(3):770-5. PubMed ID: 21257824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice.
    Koda M; Nishio Y; Kamada T; Someya Y; Okawa A; Mori C; Yoshinaga K; Okada S; Moriya H; Yamazaki M
    Brain Res; 2007 May; 1149():223-31. PubMed ID: 17391650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
    Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
    Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.